Search
Search Results
##search.searchResults.foundPlural##
-
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1104PDF: 765HTML: 295 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
689PDF: 564HTML: 87 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1306PDF: 1090PDF: 867HTML: 170 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1382HTML: 446PDF: 824 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1322PDF: 1135HTML: 120 -
HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS
9982PDF: 988HTML: 211 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1365PDF: 471HTML: 180 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3329PDF: 584HTML: 664 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
2766PDF: 1012HTML: 412TABLE: 192FIGURES: 254 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3327PDF: 723HTML: 714Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 181Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 185Table : Distribution of the sites of bleeding and their causes: 178 -
ADVANCES IN THE TREATMENT OF MALARIA
2856PDF: 1124HTML: 5992 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2152PDF: 1287Html: 284 -
-
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2917PDF: 692HTML: 1935figure 1: 169figure 2: 176 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1386PDF: 888HTML: 1824 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3514PDF: 891HTML: 1654figure 1: 165Untitled: 190 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6099PDF: 3250HTML: 9020Figure Malaria Ricci: 228 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
992PDF: 363HTML: 201 -
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1381PDF: 1220HTML: 482 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3695PDF: 1237HTML: 3901Untitled: 214Untitled: 260 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2513PDF: 840HTML: 8883Efremov 1: 229Efremov 2: 191 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1246PDF: 759HTML: 317 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
726PDF: 502HTML: 44 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1572PDF: 773HTML: 1306







